chr11-694827-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_021008.4(DEAF1):c.221G>A(p.Gly74Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000247 in 1,455,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G74R) has been classified as Uncertain significance.
Frequency
Consequence
NM_021008.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DEAF1 | NM_021008.4 | c.221G>A | p.Gly74Glu | missense_variant | 1/12 | ENST00000382409.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DEAF1 | ENST00000382409.4 | c.221G>A | p.Gly74Glu | missense_variant | 1/12 | 1 | NM_021008.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151306Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000193 AC: 2AN: 103602Hom.: 0 AF XY: 0.0000167 AC XY: 1AN XY: 60002
GnomAD4 exome AF: 0.0000253 AC: 33AN: 1303726Hom.: 0 Cov.: 32 AF XY: 0.0000295 AC XY: 19AN XY: 644950
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151306Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 73802
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 10, 2023 | This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 74 of the DEAF1 protein (p.Gly74Glu). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DEAF1 protein function. ClinVar contains an entry for this variant (Variation ID: 1675439). This variant has not been reported in the literature in individuals affected with DEAF1-related conditions. This variant is present in population databases (rs748707692, gnomAD 0.02%). - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Aug 23, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at